Global Cancer in Women: Cancer Control Priorities.
This review is an abbreviated version of a report prepared for the American Cancer Society Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, which was released at the Union for International Cancer Control World Cancer Congress in Paris in November 2016. The original report can be found at https://www.cancer.org/health-care-professionals/our-global-health-work/global-cancer-burden/global-burden-of-cancer-in-women.html. Staff in the Intramural Research Department of the American Cancer Society designed and conducted the study, including analysis, interpretation, and presentation of the review. The funding sources had no involvement in the study design, data analysis and interpretation, or preparation of the reviewThe global burden of cancer in women has recently received much attention, but there are few comprehensive reviews of the burden and policy approaches to reduce it. This article, second in series of two, summarizes the most important cancer control priorities with specific examples of proven interventions, with a particular focus on primary prevention in low- and middle-income countries (LMIC). There are a number of effective cancer control measures available to countries of all resource levels. Many of these measures are extremely cost-effective, especially in the case of tobacco control and vaccination. Countries must prioritize efforts to reduce known cancer risk factors and make prevention accessible to all. Effective treatments and palliative care are also needed for those who develop cancer. Given scarce resources, this may seem infeasible in many LMICs, but past experience with other diseases like HIV, tuberculosis, and malaria have shown that it is possible to make affordable care accessible to all. Expansion of population-based cancer registries and research in LMICs are needed for setting cancer control priorities and for determining the most effective interventions. For LMICs, all of these activities require support and commitment from the global community.Cancer Epidemiol Biomarkers Prev; 26(4); 458-70. ©2017 AACRSee related article by Torre et al. in thisCEBP Focussection, "Global Cancer in Women."
Intramural Research, American Cancer Society, Atlanta, Georgia. farhad.islami@cancer.org.
Farhad
F
Islami
Intramural Research, American Cancer Society, Atlanta, Georgia.
Lindsey A
LA
Torre
Intramural Research, American Cancer Society, Atlanta, Georgia.
Jeffrey M
JM
Drope
Intramural Research, American Cancer Society, Atlanta, Georgia.
Elizabeth M
EM
Ward
Intramural Research, American Cancer Society, Atlanta, Georgia.
Ahmedin
A
Jemal
D000393:Air Pollutants / Q000633:toxicity; D001835:Body Weight; D001943:Breast Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D055088:Early Detection of Cancer / Q000379:methods*; D015444:Exercise; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D014943:Global Health / Q000706:statistics & numerical data*; D007722:Health Knowledge, Attitudes, Practice; D006297:Health Services Accessibility; D006801:Humans; D012307:Risk Factors; D000074606:Smoking Prevention; D014611:Vaccination / Q000706:statistics & numerical data
D000393:Air Pollutants